Novobiocin acts as an inhibitor of bacterial DNA gyrase and eukaryotic DNA topoisomerases. The human topoisomerase IIalpha has been reported to be inhibited by the novobiocin. It binds at the ATP-binding site and thus prevents the binding of ATP to the enzyme. This structure is the complex of hTopoIIalpha and novobiocin bound at both the ATP-binding sites.